Redeye Theme: Orphan Drugs

April 27 2022

11:00-14:00

Live broadcast at redeye.se

April 27 2022

11:00-14:00

Live broadcast at redeye.se

Live broadcast at redeye.se

Live events are available to Redeye members

Sign up for a free membership

Already a member?

Sign in

Live broadcast at redeye.se

For the third consecutive year, Redeye hosts a seminar on ‘Drug development in orphan indications.’

 

Targeting rare diseases come with several advantages in the regulatory, clinical development, and commercial stage. We find some of the biotech success stories on the stock market in this space. A couple of the companies stand on the verge of commercialization.

 

This is a unique opportunity for investors interested in this space. The participating companies will share their equity story, project status, and triggers ahead.

 

Following the presentations, Redeye’s analysts will hold Q&A sessions where questions are open for the audience.

 

NOTE!
Companies and schedules may change before the event starts.

You can save the date in your calendar by using Add to calendar.

NOTE

Companies and schedules may change before the event starts. Save the date to your calendar by using Add to calendar.